Clinical Trend of the Week (August 13-19): Psoriasis
Some bad news and some good news helped drive our top search this week. A recent study determined that psoriasis is associated with a significantly higher risk of chronic pancreatitis (CP). The incidence of CP was almost double in individuals with psoriasis than among those in the control group. The good news comes in the form of a new clinical trial that could change treatment for adults who have moderate-to-severe plaque psoriasis. A phase 2/3 clinical trial found that Piclidenoson is safe and possibly more effective than apremilast (Otezla), which is already approved for plaque psoriasis treatment. This is particularly welcome news because nearly 70% of biological treatments are discontinued by patients with moderate-to-severe psoriasis due to side effects or loss of efficacy. A busy news week helped push this term into the top spot.
For more information on psoriasis, read here.
Medscape © 2016
WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Ryan Syrek. Clinical Trends for August 2016 - Medscape - Aug 05, 2016.
Comments